Streetbeat News

Earnings

TOI

The Oncology Institute (NASDAQ:TOI) reported Q4 2023 earnings with a GAAP EPS of $(0.21), missing the $(0.11) estimate by 90.91%, but sales of $85.788M exceeded the $82.042M estimate by 4.57%, marking a 20.11% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 8:28 pm

FUL

H.B. Fuller's stock price declined following the announcement of mixed financial results for the first quarter. The company's performance did not fully meet market expectations, leading to a negative reaction from investors.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 8:26 pm

PLBY

PLBY Group (NASDAQ:PLBY) reported Q4 earnings with an EPS of $-0.05, beating estimates by 64.0% but with a revenue decrease of $29.15 million from the previous year. The company had previously missed EPS estimates last quarter, resulting in a 25.0% share price drop the following day. The report provides a detailed comparison of PLBY's performance over the last four quarters, highlighting fluctuations in EPS and revenue.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 8:25 pm

PLBY

PLBY Group reported Q4 2023 earnings with a GAAP EPS of $(0.05), surpassing the $(0.14) estimate. Sales reached $39.364M, exceeding the $32.275M forecast but marking a 12.31% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 8:24 pm

CXM

Sprinklr (NYSE:CXM) reported Q4 earnings of $0.12 per share, surpassing the $0.09 estimate, a 100% increase from last year. Sales reached $194.21M, beating the $188.73M estimate, marking a 17.47% increase from the previous year.

Portfolio Pulse from Happy Mohamed

March 27, 2024 | 8:23 pm

RH

RH shares are trading higher following the announcement of their Q4 financial results and the issuance of future guidance.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 8:21 pm

MREO

Mereo BioPharma Group (NASDAQ:MREO) reported a narrower quarterly loss of $(0.04) per share, improving from $(0.07) per share year-over-year, with sales reaching $10.00 million.

Portfolio Pulse from Happy Mohamed

March 27, 2024 | 8:21 pm

BRZE

Braze (NASDAQ:BRZE) reported Q4 earnings with EPS of $(0.04), surpassing the $(0.05) estimate, and sales of $130.96M, exceeding the $124.86M estimate. This represents a significant improvement over the previous year, with a 71.43% increase in EPS and a 32.72% increase in sales.

Portfolio Pulse from dijoy@benzinga.com

March 27, 2024 | 8:17 pm

USIO

Usio reported Q4 sales of $19.363M, missing the analyst consensus estimate of $20.427M by 5.21%. This represents a 3.52% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 8:17 pm

JEF

Jefferies Financial Group (JEF) reported Q1 earnings of $0.87 per share, surpassing the $0.75 estimate, a 58.18% increase from last year. Sales reached $1.74B, beating the $1.52B estimate, marking a 35.48% increase from the previous year.

Portfolio Pulse from Happy Mohamed

March 27, 2024 | 8:16 pm